关注
Anton Buzdin
Anton Buzdin
Chief Scientific Officer, PhD
在 oncobox.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Cutting edge: activation of STING in T cells induces type I IFN responses and cell death
B Larkin, V Ilyukha, M Sorokin, A Buzdin, E Vannier, A Poltorak
The Journal of Immunology 199 (2), 397-402, 2017
2842017
Genetics and epigenetics of aging and longevity
A Moskalev, A Aliper, Z Smit-McBride, A Buzdin, A Zhavoronkov
Cell Cycle 13 (7), 1063-1077, 2014
2152014
Retroelements and their impact on genome evolution and functioning
E Gogvadze, A Buzdin
Cellular and molecular life sciences 66, 3727-3742, 2009
1682009
Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis
J Sarhan, BC Liu, HI Muendlein, CG Weindel, I Smirnova, AY Tang, ...
Cell Death & Differentiation 26 (2), 332-347, 2019
1632019
FDA-approved and emerging next generation predictive biomarkers for immune checkpoint inhibitors in cancer patients
Y Wang, Z Tong, W Zhang, W Zhang, A Buzdin, X Mu, Q Yan, X Zhao, ...
Frontiers in oncology 11, 683419, 2021
1402021
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
IV Ozerov, KV Lezhnina, E Izumchenko, AV Artemov, S Medintsev, ...
Nature communications 7 (1), 13427, 2016
1392016
A role for GCSF and GMCSF in nonmyeloid cancers
AM Aliper, VP FriedenKorovkina, A Buzdin, SA Roumiantsev, ...
Cancer medicine 3 (4), 737-746, 2014
1312014
The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination
A Buzdin, E Gogvadze, E Kovalskaya, P Volchkov, S Ustyugova, ...
Nucleic acids research 31 (15), 4385-4390, 2003
1292003
At least 50% of human-specific HERV-K (HML-2) long terminal repeats serve in vivo as active promoters for host nonrepetitive DNA transcription
A Buzdin, E Kovalskaya-Alexandrova, E Gogvadze, E Sverdlov
Journal of virology 80 (21), 10752-10762, 2006
1272006
A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 3′ terminus of l1
A Buzdin, S Ustyugova, E Gogvadze, T Vinogradova, Y Lebedev, ...
Genomics 80 (4), 402-406, 2002
1232002
Molecular functions of human endogenous retroviruses in health and disease
M Suntsova, A Garazha, A Ivanova, D Kaminsky, A Zhavoronkov, ...
Cellular and Molecular Life Sciences 72, 3653-3675, 2015
1042015
Human-specific subfamilies of HERV-K (HML-2) long terminal repeats: three master genes were active simultaneously during branching of hominoid lineages
A Buzdin, S Ustyugova, K Khodosevich, I Mamedov, Y Lebedev, ...
Genomics 81 (2), 149-156, 2003
1022003
Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH
M Suntsova, EV Gogvadze, S Salozhin, N Gaifullin, F Eroshkin, ...
Proceedings of the National Academy of Sciences 110 (48), 19472-19477, 2013
1012013
Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data
AA Buzdin, AA Zhavoronkov, MB Korzinkin, LS Venkova, AA Zenin, ...
Frontiers in genetics 5, 55, 2014
992014
Atlas of RNA sequencing profiles for normal human tissues
M Suntsova, N Gaifullin, D Allina, A Reshetun, X Li, L Mendeleeva, ...
Scientific data 6 (1), 36, 2019
972019
Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells
AM Aliper, AB Csoka, A Buzdin, T Jetka, S Roumiantsev, A Moskalev, ...
Aging (Albany NY) 7 (1), 26, 2015
902015
H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 histone tags suggest distinct regulatory evolution of open and condensed chromatin landmarks
AA Igolkina, A Zinkevich, KO Karandasheva, AA Popov, MV Selifanova, ...
Cells 8 (9), 1034, 2019
792019
Molecular pathway activation–new type of biomarkers for tumor morphology and personalized selection of target drugs
A Buzdin, M Sorokin, A Garazha, M Sekacheva, E Kim, N Zhukov, Y Wang, ...
Seminars in cancer biology 53, 110-124, 2018
792018
Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling
PV Spirin, TD Lebedev, NN Orlova, AS Gornostaeva, MM Prokofjeva, ...
Leukemia 28 (11), 2222-2228, 2014
782014
Signaling pathways activation profiles make better markers of cancer than expression of individual genes
NM Borisov, NV Terekhanova, AM Aliper, LS Venkova, PY Smirnov, ...
Oncotarget 5 (20), 10198, 2014
782014
系统目前无法执行此操作,请稍后再试。
文章 1–20